Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2736
Gene Symbol: GLI2
GLI2
0.010 AlteredExpression disease BEFREE Indeed, mutations in THP cause a group of inherited kidney diseases, and altered THP expression is associated with increased risks of urinary tract infection, kidney stone, hypertension, hyperuricemia and acute and chronic kidney diseases. 30649494 2020
Entrez Id: 2475
Gene Symbol: MTOR
MTOR
0.010 Biomarker disease BEFREE Deregulated MTOR (mechanistic target of rapamycin kinase) is responsible for autophagy defects exacerbating kidney stone development. 31257986 2020
Entrez Id: 221883
Gene Symbol: HOXA11-AS
HOXA11-AS
0.010 Biomarker disease BEFREE Taken together, HOXA11-AS mediated CaOx crystal-induced renal inflammation via the miR-124-3p/MCP-1 axis, and this outcome may provide a good potential therapeutic target for nephrolithiasis. 31680444 2020
Entrez Id: 2925
Gene Symbol: GRPR
GRPR
0.010 AlteredExpression disease BEFREE Taken together, we conclude that GRPR gene silencing suppresses the development of the EMT and formation of the calcium oxalate crystal in renal TECs of kidney stones through the inactivation of the PI3K/Akt signaling pathway. 30144073 2019
Entrez Id: 5450
Gene Symbol: POU2AF1
POU2AF1
0.010 GeneticVariation disease BEFREE Of the four signals associated with urine pH, we note that the pH-increasing alleles of two variants (POU2AF1, WDR72) associate significantly with increased risk of kidney stones. 30476138 2019
Entrez Id: 2944
Gene Symbol: GSTM1
GSTM1
0.010 GeneticVariation disease BEFREE GSTM1 and GSTT1 null genotypes are not a risk features for nephrolithiasis. 31445152 2019
Entrez Id: 5599
Gene Symbol: MAPK8
MAPK8
0.010 Biomarker disease BEFREE ROS and JNK pathways may contribute to CNP-induced cell injury and kidney stone formation. 29511793 2019
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.010 GeneticVariation disease BEFREE Inhibiting inflammation and modulating oxidative stress in oxalate-induced nephrolithiasis with the Nrf2 activator dimethyl fumarate. 30599261 2019
Entrez Id: 9429
Gene Symbol: ABCG2
ABCG2
0.010 GeneticVariation disease BEFREE ABCG2 SNP rs2231142 and the gout comorbidities including nephrolithiasis and CKD were associated (<i>P</i> = 0.014 and <i>P</i> = 0.026). 31367212 2019
Entrez Id: 2023
Gene Symbol: ENO1
ENO1
0.010 AlteredExpression disease BEFREE These data indicate that finasteride effectively protects testosterone-induced kidney stone formation by restoring apical surface expression of α-enolase and COM crystal-cell adhesion to their basal levels. 31342142 2019
Entrez Id: 8527
Gene Symbol: DGKD
DGKD
0.010 GeneticVariation disease BEFREE In a validation cohort of only nephrolithiasis patients, the CYP24A1-associated locus correlates with serum calcium concentration and a number of nephrolithiasis episodes while the DGKD-associated locus correlates with urinary calcium excretion. 31729369 2019
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.010 Biomarker disease BEFREE Peroxisome proliferator-activated receptor γ (PPARγ) has been shown to be critical for the regulation of cell transdifferentiation in many physiological and pathological conditions; however, little is known about its role in kidney stone formation. 30317563 2019
Entrez Id: 5420
Gene Symbol: PODXL
PODXL
0.010 AlteredExpression disease BEFREE Evaluation of the urinary podocalyxin and nephrin excretion levels to determine a safe time interval between two sessions of SWL for renal stones: a non randomized exploratory study. 31321677 2019
Entrez Id: 5312
Gene Symbol: PKD3
PKD3
0.010 Biomarker disease BEFREE This case is the first case of combine presentation on PKD1 and PKD3 in a pediatric patient with nephrolithiasis. 30792735 2019
Entrez Id: 22915
Gene Symbol: MMRN1
MMRN1
0.010 Biomarker disease BEFREE Fibronectin, an extracellular matrix (ECM) protein, has been thought to be involved in pathogenic mechanisms of kidney stone disease, especially calcium oxalate (CaOx) type. 30701361 2019
Entrez Id: 9213
Gene Symbol: XPR1
XPR1
0.010 AlteredExpression disease BEFREE Activation of liver X receptor suppresses osteopontin expression and ameliorates nephrolithiasis. 30623435 2019
Entrez Id: 2308
Gene Symbol: FOXO1
FOXO1
0.010 AlteredExpression disease BEFREE The results showed that human peripheral blood monocytes from patients with kidney stone (KS) exhibited decreased M2 monocytes percentage and SIRT3 expression, whereas increased FOXO1 acetylation compared with the normal controls. 30588609 2019
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.010 GeneticVariation disease BEFREE This work is the first in the literature to study the relation between eNOs genes polymorphisms and nephrolithiasis. 31445152 2019
Entrez Id: 256764
Gene Symbol: WDR72
WDR72
0.010 GeneticVariation disease BEFREE Of the four signals associated with urine pH, we note that the pH-increasing alleles of two variants (POU2AF1, WDR72) associate significantly with increased risk of kidney stones. 30476138 2019
Entrez Id: 50507
Gene Symbol: NOX4
NOX4
0.010 Biomarker disease BEFREE In conclusion, OA could be used as a NOX4 inhibitor to prevent kidney stones. 31117291 2019
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.010 AlteredExpression disease BEFREE Taken together, we conclude that GRPR gene silencing suppresses the development of the EMT and formation of the calcium oxalate crystal in renal TECs of kidney stones through the inactivation of the PI3K/Akt signaling pathway. 30144073 2019
Entrez Id: 114548
Gene Symbol: NLRP3
NLRP3
0.010 Biomarker disease BEFREE Long noncoding RNA LINC00339 promotes renal tubular epithelial pyroptosis by regulating the miR-22-3p/NLRP3 axis in calcium oxalate-induced kidney stone. 30614043 2019
Entrez Id: 5310
Gene Symbol: PKD1
PKD1
0.010 Biomarker disease BEFREE This case is the first case of combine presentation on PKD1 and PKD3 in a pediatric patient with nephrolithiasis. 30792735 2019
Entrez Id: 5087
Gene Symbol: PBX1
PBX1
0.010 AlteredExpression disease BEFREE We postulate that the presence of this SNP alters the expression of PBX1, thus affecting the renal absorption of cystine and other amino acids, predisposing to nephrolithiasis. 30450686 2019
Entrez Id: 5251
Gene Symbol: PHEX
PHEX
0.010 GeneticVariation disease BEFREE Hypophosphatemic rickets, mostly of the X-linked dominant form caused by pathogenic variants of the PHEX gene, poses therapeutic challenges with consequences for growth and bone development and portends a high risk of fractions and poor bone healing, dental problems and nephrolithiasis/nephrocalcinosis. 30454743 2019